Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients

Aims: To measure pimecrolimus blood concentrations and to evaluate tolerability and efficacy in children and infants treated topically for atopic dermatitis with pimecrolimus cream 1% for three weeks. Methods: Three open label, non-controlled, multiple topical dose studies were conducted in children...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Allen, B, Lakhanpaul, M, Morris, A, Lateo, S, Davies, T, Scott, G, Cardno, M, Ebelin, M, Burtin, P, Stephenson, T
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2003
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1719352/
https://ncbi.nlm.nih.gov/pubmed/14612358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/adc.88.11.969
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller